Table 1

Baseline clinical and procedural characteristics

Clinical characteristics (nā€Š=ā€Š73 patients)
Demographics
Age (years), mean (SD)62 (10)
Male (%)57 (78.1)
HT (%)44 (60.3)
DM (%)14 (19.2)
Dyslipidaemia (%)46 (63)
Smoker (%)22 (30.1)
Family history (%)25 (34.2)
Cardiac history
Previous MI (%)28 (38.4)
Previous CABG (%)2 (2.7)
Previous PCI (%)27 (37)
Clinical presentation
Stable angina (%)41 (56.2)
Unstable angina (%)22 (30.1)
STEMI (%)10 (13.7)
Procedural characteristics (nā€Š=ā€Š80 vessels)
Vessel
LAD (%)41 (51.3)
LCX (%)12 (15)
RCA (%)27 (33.8)
Stent type
BMS (%)14 (17.5)
Paclitaxel-eluting stent (%)5 (6.3)
Sirolimus-eluting stent (%)4 (5)
Everolimus-eluting stent (%)44 (55)
Zotarolimus-eluting stent (%)12 (15)
Tacrolimus-eluting stent (%)1 (1.3)
Other data
Number of stents, mean (SD)1.6 (0.8)
Stent diameter, mean (SD)3.0 (0.4)
Stent length, mean (SD)33 (17)
Implantation pressure, mean (SD)16.8 (3)
Predilatation39 (48.8)
Postdilatation34 (42.5)
Rotational atherectomy1 (1.3)
Thrombectomy5 (6.3)
  • Results are shown as number (%) unless stated otherwise.

  • BMS, bare metal stent; CABG, coronary artery bypass graft surgery; DM, diabetes mellitus; HT, hypertension; LAD, left anterior descending coronary artery; LCX, left circumflex artery; MI, myocardial infarction; PCI, percutaneous coronary intervention; RCA, right coronary artery; STEMI, ST elevation myocardial infarction.